These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23114776)

  • 41. Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine.
    Jamal MA; Rosenblatt JS; Hachem RY; Ying J; Pravinkumar E; Nates JL; Chaftari AM; Raad II
    Antimicrob Agents Chemother; 2014; 58(2):1179-82. PubMed ID: 24165191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.
    Darouiche RO; Mansouri MD; Gawande PV; Madhyastha S
    J Antimicrob Chemother; 2009 Jul; 64(1):88-93. PubMed ID: 19447791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An in vitro study of the efficacy of rifampicin and minocycline coated umbilical venous catheters.
    Norton RE; Patole S; Whitehall J
    Int J Antimicrob Agents; 2001 Mar; 17(3):237-40. PubMed ID: 11282272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance.
    Hoban DJ; Jones RN; Harrell LJ; Knudson M; Sewell D
    Diagn Microbiol Infect Dis; 1993; 17(2):157-61. PubMed ID: 8243037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
    Prosser BL; Beskid G
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):33-45. PubMed ID: 7789095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters.
    Sampath LA; Tambe SM; Modak SM
    Infect Control Hosp Epidemiol; 2001 Oct; 22(10):640-6. PubMed ID: 11776351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.
    Yamane N; Jones RN; Frei R; Hoban DJ; Pignatari AC; Marco F
    J Chemother; 1994 Apr; 6(2):83-91. PubMed ID: 8077990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria.
    Eng RH; Padberg FT; Smith SM; Tan EN; Cherubin CE
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1824-8. PubMed ID: 1952852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties.
    Lim K; Chua RR; Bow H; Tambyah PA; Hadinoto K; Leong SS
    Acta Biomater; 2015 Mar; 15():127-38. PubMed ID: 25541344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection.
    Ranucci M; Isgrò G; Giomarelli PP; Pavesi M; Luzzani A; Cattabriga I; Carli M; Giomi P; Compostella A; Digito A; Mangani V; Silvestri V; Mondelli E;
    Crit Care Med; 2003 Jan; 31(1):52-9. PubMed ID: 12544993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
    Malmborg AS; Ahlén S
    Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms.
    Passerini de Rossi B; Feldman L; Pineda MS; Vay C; Franco M
    J Med Microbiol; 2012 Sep; 61(Pt 9):1248-1253. PubMed ID: 22580911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative antimicrobial activity and spectrum of CP-99,219, a novel fluoroquinolone, tested against ciprofloxacin-resistant clinical isolates.
    Murphy SP; Cormican MG; Jones RN
    Ir J Med Sci; 1995; 164(4):271-3. PubMed ID: 8522427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of DNase and antibiotics on biofilm characteristics.
    Tetz GV; Artemenko NK; Tetz VV
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1204-9. PubMed ID: 19064900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotics and prevention of microbial colonization of catheters.
    Raad I; Darouiche R; Hachem R; Sacilowski M; Bodey GP
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2397-400. PubMed ID: 8585715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter.
    Schierholz JM; Nagelschmidt K; Nagelschmidt M; Lefering R; Yücel N; Beuth J
    Anticancer Res; 2010 Apr; 30(4):1353-8. PubMed ID: 20530452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chelator-based catheter lock solutions in eradicating organisms in biofilm.
    Raad I; Rosenblatt J; Reitzel R; Jiang Y; Dvorak T; Hachem R
    Antimicrob Agents Chemother; 2013 Jan; 57(1):586-8. PubMed ID: 23070163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel synergistic antibiofilm combinations for salvage of infected catheters.
    Venkatesh M; Rong L; Raad I; Versalovic J
    J Med Microbiol; 2009 Jul; 58(Pt 7):936-944. PubMed ID: 19502361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):305-9. PubMed ID: 10385024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.